Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti‐tumor efficacy
暂无分享，去创建一个
A. Alexeyenko | B. Janji | S. Parpal | A. De Milito | M. Noman | J. Viklund | M. Bogdan | Kris van Moer | Katja Pokrovskaja Tamm | M. Andersson | C. Silvander | Yasmin Yu | J. Martinsson | Hikmat Al-Hashimi | D. Flynn | M. J. Timson | Bryan D. Smith | Simone C. Kleinendorst | Elisabetta Bartolini | Kristine Bilgrav Saether | Lionel Trésaugues | Johan Lindström | Jodi Simeon